Ascidian Therapeutics said on Wednesday it has signed a licensing deal for its gene-editing technology with pharma major Eli ...
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like ...
Albert Luderer assumed the role of Interim CEO, with Erik [last name not specified] remaining as an advisor to ensure ...
Opinion
The Sunday Guardian Live on MSNOpinion
Kuhn-Pasteur to AGI-Quantum: R&D frontiers in superposition - Vatsal Soin's 0->1 doctrine gates future cascades
India, May 27 -- Without Governance AGI Hallucinates. Agentic Swarms Act Without Authorisation. Humanoid Robots Move Without Proof. Quantum Systems Compute Without Boundaries. The Singularity ...
Summary: Researchers uncovered a sex-specific molecular process that dictates how the female brain forms and consolidates fear memories. The study demonstrates that women are twice as likely as men to ...
Tilmann Buerckstuemmer, PhD, is a CRISPR enthusiast since the early days of CRISPR. Originally trained as a biochemist, he joined Haplogen as principal scientist and later became their CSO. Following ...
Perturb-FISH aims to address both challenges. Because this technique harnesses imaging spatial transcriptomics (iST), it offers high resolution and scalability, as well as relatively low costs. To ...
Earnings call Bionano Genomics delivered Q1 2026 revenue of $6.7M, up 4% YoY and at the high end of guidance, with consumable revenue up 20% and flow cell unit sales up 17%. Adjusted gross margin ...
Isaac Taylor is a reporter for WSJ Pro, The Wall Street Journal’s premium subscription service, where he specializes in private credit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results